MedPath

Effect of a Diet and Physical Activity Intervention in Breast Cancer Survivors

Phase 2
Completed
Conditions
Breast Cancer
Registration Number
NCT02067481
Lead Sponsor
Institut Català d'Oncologia
Brief Summary

This is a single-arm pre-post pilot study, to assess changes in weight, quality of life and cardiorespiratory fitness after a diet and physical activity intervention in breast cancer survivors and to asses possible relation between these changes.

Detailed Description

Aim:

The present study assessed changes in weight, quality of life (QoL) and cardiorespiratory fitness (CRF) during a diet and physical activity (PA) intervention in breast cancer (BC) survivors and investigated the possible relation between these changes.

Methods:

The intervention of this 12-week single-arm pre-post pilot study involved group-based sessions: one-hour weekly diet sessions delivered by a dietician and 75-minute bi-weekly PA sessions of moderate-to-high intensity led by PA monitors. This intervention, designed to promote weight loss, targeted overweight/obese women who had completed treatment less than six months before recruitment. CRF and QoL were assessed before and after the intervention and compared using paired t-tests. Linear regression models, including CRF variables, weight change and participants' characteristics, were used to assess the independent association between change in CRF and change in QoL.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
42
Inclusion Criteria
  • Female patients from the Catalan Institute of Oncology
  • Aged 18 to 75
  • Body mass index (BMI) of 25 kg•m-2 or more
  • Completed chemotherapy and/or radiotherapy for breast cancer during the 6 months preceding recruitment
Exclusion Criteria
  • First cancer, tumours of stage IIIB and above
  • Morbid obesity (BMI ≥40 kg•m-2)
  • Any condition that could not permit to follow the diet and PA intervention offered

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Weight loss3 months

Loss 3% of the initial weight

Secondary Outcome Measures
NameTimeMethod
Quality of life3 months

EORTC QLQ-C30 and BR23 mean scores

Trial Locations

Locations (1)

Instituto Catalá de Oncología

🇪🇸

Barcelona, L´Hospitalet de Llobregat, Spain

Instituto Catalá de Oncología
🇪🇸Barcelona, L´Hospitalet de Llobregat, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.